INDIA
MONEY
TRAVELLER
LUXE
HINDI
EATS

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Markets
News
Corporate
AI
Magazine
OB DataLens
In Depth
Economy & Policy
Videos
Start-Up
Planet

News
Magazine
Markets
In Depth
Economy & Policy
Videos
Start-Up
Planet
Corporate
Tech
AI
Budget 2025
Spotlight
Magazine Special Edition
Initiatives
- Spotlight
- C3
About Us

Markets
News
Corporate
AI
Magazine
OB DataLens
In Depth
Economy & Policy
Videos
Start-Up
Planet

home
Topic
Dr reddys labs

Dr Reddys Labs

Dr Reddy’s Lab Shares Rise 4% On Pact With Alvotech For Biosimilar Development

Dr Reddy’s Lab Shares Rise 4% On Pact With Alvotech For Biosimilar Development

BY Outlook Business Desk

Dr Reddy Laboratories

Dr Reddy's PAT Zooms 18% To Rs 1,402 Crore In Q1

BY PTI

Dr Reddys Laboratories recalls 4,320 bottles of Tacrolimus Capsules in the US

Dr Reddy's Lab Recalls Over 4,000 Bottles Of Generic Drug In US

BY PTI

Pharma sector

Dr Reddy's, Sun Pharma Recall Products In US For Manufacturing Issues

BY Press Trust of India

Dr Reddy Laboratories

Intercept Pharmaceuticals Settles Ocaliva Patent Litigation Case With Dr Reddy's

BY Press Trust of India

Dr Reddys Launches Cancer Treatment Injection Bortezomib In US

Dr Reddy's Launches Cancer Treatment Injection Bortezomib In US

BY Press Trust of India

Stock Market Today: Sensex Falls Over 200 Points, Nifty Below 15,300

Stock Market Today: Sensex Falls Over 200 Points, Nifty Below 15,300

BY Outlook Business Team

Close Ad

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2025 Outlook Publishing India Pvt Ltd.

Copyright © 2025 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.